Skip to main content
Figure 1 | Trials

Figure 1

From: The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial

Figure 1

Study flowchart. Overall, 186 patients meeting the inclusion criteria and no exclusion criteria are randomly assigned to two treatment arms. Especially, present SBP has to be ruled out, and patients have to be verified to carry at least one of the three common NOD2 variants. It is expected that about 1,400 patients need to be evaluated to finally randomize the calculated 186 patients. SBP, Spontaneous bacterial peritonitis.

Back to article page